GlassScriptPhysician profile
Walid J Baddoura
NPI 1043253578
$6,819.07
in general payments reported to CMS, 2019-2025
24 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $645 · 2021: $140 · 2022: $690 · 2023: $974 · 2024: $2,211 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,278.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,065.43 | 2019-2025 | Skyrizi, Rinvoq, Mavyret |
| Gilead Sciences, INC. | $815.01 | 2019-2025 | Livdelzi, Epclusa |
| Madrigal Pharmaceuticals | $542.86 | 2024-2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $412.11 | 2019-2025 | Entyvio |
| E.R. Squibb & Sons, L.L.C. | $367.21 | 2023-2024 | Zeposia |
| Janssen Biotech, INC. | $290.32 | 2025 | Tremfya |
| Boston Scientific Corporation | $286.81 | 2020-2025 | Resolution 360 Clip, Exalt Model D |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $265.58 | 2019 | |
| Olympus America INC. | $209.93 | 2019-2024 | Endoclot Phs |
| Allergan, INC. | $196.43 | 2019-2020 | |
| Medical Device Business Services, INC. | $146.58 | 2024 | Linx Reflux Management System |
| Ipsen Biopharmaceuticals, INC | $129.65 | 2025 | Iqirvo |
| Sirtex Medical INC | $126.99 | 2019-2020 | |
| Qol Medical, LLC | $125.00 | 2024 | Sucraid |
| Phathom Pharmaceuticals, INC. | $114.58 | 2024 | Voquezna |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $112.26 | 2020 | |
| Janssen Scientific Affairs, LLC | $107.93 | 2019 | |
| Pfizer INC. | $104.66 | 2024 | |
| Intercept Pharmaceuticals, INC. | $99.14 | 2022 | |
| Ironwood Pharmaceuticals, INC | $96.59 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.47 | 2019-2022 | |
| Medtronic, INC. | $74.36 | 2021-2024 | Gi Genius |
| Capsovision, INC. | $30.59 | 2023 | Capsocam Plus |
| Merck Sharp & Dohme LLC | $14.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walid Baddoura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.